• ADM to open new lab to conduct enzyme research and development

CHICAGO–(BUSINESS WIRE)–Archer Daniels Midland Company (NYSE: ADM) and Qingdao Vland Biotech
Group Co., Ltd. today announced a joint development agreement for the
development and commercialization of enzymes for animal feed
applications. In addition to ADM’s research center in Decatur, Illinois,
ADM will open a new U.S. enzyme research and development lab in
California that will directly support activities being undertaken in the
joint development agreement. Vland will also conduct research and
development in its Qingdao research laboratory, which will be upgraded
to a new state-of-the-art facility.

Under the terms of the agreement, the companies will share
enzyme-producing strains as a basis for the development of feed enzymes
that will improve animal nutrition and health. Products developed under
the agreement will be commercialized by both companies.

“This agreement and the opening of our new enzyme lab will significantly
enhance our ability to develop products for the fast-growing enzyme
market,” said Todd Werpy, ADM’s chief technology officer. “The agreement
will give our research and development team access to new enzyme
strains, and the new U.S.-based enzyme research lab will provide us with
the resources to use those strains to develop new, state-of-the-art feed
enzymes. We’re looking forward to adding these capabilities to our
already strong array of animal nutrition products and solutions.”

“This agreement is another important step as we continue to expand our
capabilities in bioactives, including enzymes and novel ingredients for
the food, pharmaceutical and animal feed industries,” said Vikram
Luthar, ADM’s president, bioactives. “We are continuing to build our
portfolio in order to offer complete and innovative solutions to
customers in these exciting and rapidly growing markets.”

“As a high-tech enterprise focused on enzymes, Vland is committed to
seeking partners around the world to build a global technological
innovation system,” said Vland president Chen Gang. “This agreement
between Vland and ADM to engage in the development of feed enzymes, and
the establishment of new research centers in the U.S. and Qingdao, are
important steps. We are looking forward to future collaborations and the
opportunity to offer effective solutions to customers in this exciting
and rapidly growing market.”

About Vland

Vland Biotech Inc., is one of the leading biotechnology companies in
China. Based in Qingdao, the company specializes in four product
categories: enzymes, probiotics, vaccines and animal health products.
Vland provides solutions for an ever-expanding list of industries,
including agriculture, animal husbandry, textile, paper making,
household cleaning and detergents, food, biofuel, environmental
protection and more.

About ADM

For more than a century, the people of Archer Daniels Midland Company
(NYSE: ADM) have transformed crops into products that serve the vital
needs of a growing world. Today, we’re one of the world’s largest
agricultural processors and food ingredient providers, with
approximately 32,000 employees serving customers in more than 160
countries. With a global value chain that includes approximately 500
crop procurement locations, 250 ingredient manufacturing facilities, 38
innovation centers and the world’s premier crop transportation network,
we connect the harvest to the home, making products for food, animal
feed, industrial and energy uses. Learn more at www.adm.com.

Contacts

Archer Daniels Midland Company
Media Relations
Jackie
Anderson
312-634-8484
[email protected]